Apolipoprotein CI knock-out mice display impaired memory functions

Wet-wrap treatment using dilutions of tacrolimus ointment and fluticasone propionate cream in human APOC1 (+/+) mice with atopic dermatitis

Apolipoprotein CI inhibits scavenger receptor BI and increases plasma HDL levels in vivo

Plasma apolipoprotein CI protects against mortality from infection in old age

Preoperative apolipoprotein CI levels correlate positively with the proinflammatory response in patients experiencing endotoxemia following elective cardiac surgery

Plasma apolipoprotein CI correlates with increased survival in patients with severe sepsis

Development of atopic dermatitis in mice transgenic for human apolipoprotein C1

ApoE2-associated hypertriglyceridemia is ameliorated by increased levels of apoA-V but unaffected by apoC-III deficiency

Human apolipoprotein C-I expression in mice impairs learning and memory functions

Apolipoprotein CI aggravates atherosclerosis development in ApoE-knockout mice despite mediating cholesterol efflux from macrophages

Hepatic lipid accumulation in apolipoprotein C-I-deficient mice is potentiated by cholesteryl ester transfer protein

Apolipoprotein C-I is crucially involved in lipopolysaccharide-induced atherosclerosis development in apolipoprotein E-knockout mice

Apolipoprotein C-I binds free fatty acids and reduces their intracellular esterification

Apolipoprotein CI stimulates the response to lipopolysaccharide and reduces mortality in gram-negative sepsis.

Endogenous apoC-I increases hyperlipidemia in apoE-knockout mice by stimulating VLDL production and inhibiting LPL

Apolipoprotein CI overexpression is not a relevant strategy to block cholesteryl ester transfer protein (CETP) activity in CETP transgenic mice

ApoC-III deficiency prevents hyperlipidemia induced by apoE overexpression

Severe hypertriglyceridemia in human APOC1 transgenic mice is caused by apoC-I-induced inhibition of LPL

Overexpression of APOC1 in obob mice leads to hepatic steatosis and severe hepatic insulin resistance

Apolipoprotein CI deficiency markedly augments plasma lipoprotein changes mediated by human cholesteryl ester transfer protein (CETP) in CETP transgenic/apoCI-knocked out mice